Search for: "WATSON PHARMACEUTICALS " Results 61 - 80 of 360
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jan 2012, 9:05 pm by Patent Docs
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
11 Jul 2012, 3:30 am
There are currently 26 federal level lawsuits regarding fentanyl patches, all filed against Watson Pharmaceuticals. [read post]
13 Sep 2015, 9:21 pm by Patent Docs
Senju Pharmaceutical Co. et al. v. [read post]
15 Sep 2013, 9:42 pm by Patent Docs
• Defendant: Watson Laboratories Inc. [read post]
16 Jun 2013, 9:32 pm by Patent Docs
Watson Laboratories Inc. et al. 1:13-cv-01015; filed June 6, 2013 in the District Court of Delaware • Plaintiff: Fresenius Kabi USA, LLC • Defendants: Watson Laboratories Inc.; Actavis Inc. [read post]
11 Jun 2012, 4:23 pm by admin
Watson Pharmaceuticals and European Commission’s clearance of the EMI Group’s music publishing business by Sony Corporation). ____________________ For more information about our regulatory law services contact: contact [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Watson Pharmaceuticals Inc., Watson Laboratories Inc. and Watson Pharma Inc. [read post]
27 Mar 2011, 9:28 pm by Patent Docs
Watson Laboratories, Inc. [read post]
7 Dec 2017, 9:34 pm by Patent Docs
Seeking approval to market generic versions of Eli Lilly's Axiron® testosterone applicator, Defendants Perrigo Company and Perrigo Israel Pharmaceuticals Ltd., Actavis Laboratories UT, Inc., FKA Watson Laboratories Inc., Lupin Pharmaceuticals, Inc. and Lupin Ltd., and Amneal Pharmaceuticals LLC filed... [read post]
9 Jan 2013, 11:01 pm by Courtenay Brinckerhoff
Watson Pharmaceuticals, Inc., to address whether and when “reverse payment” agreements made to settle ANDA litigation violate antitrust laws. [read post]
17 Aug 2010, 10:51 am by Mike Scarcella
A judge in Washington today ruled the Federal Trade Commission's subpoena seeking the testimony of the chief executive officer of generic drug maker Watson Pharmaceuticals should be enforced. [read post]
9 Mar 2008, 7:26 pm
Duramed Pharmaceuticals, Inc. v. [read post]
7 Mar 2012, 12:49 am by Kevin LaCroix
On March 7, 2012, Towers Watson released the report of its 2011 Directors and Officers Liability Survey. [read post]
13 Feb 2010, 5:02 pm by Rebecca Tushnet
Watson Pharmaceuticals, Inc., 2010 WL 446132 (D.N.J.) [read post]
13 Jan 2013, 9:06 pm by Patent Docs
.; Watson Pharmaceuticals, Inc.; Watson Laboratories, Inc.; Watson Pharma, Inc. [read post]
10 Mar 2013, 9:59 pm by Patent Docs
Searle LLC; Pfizer Asia Pacific PTE, LTD.; • Defendants: Lupin Pharmaceuticals, Inc.; Teva Pharmaceuticals USA, Inc.; Mylan Pharmaceuticals Inc.; Watson Laboratories, Inc.; Apotex Inc.; Apotex Corp. [read post]
26 Dec 2011, 1:38 pm by mikedavidson
The generic version, called Ventura, is marketed and sold by Watson Pharmaceuticals. [read post]